- Braveheart Investment Group said it now held investments in five strategic investments after recent acquisition and structural changes in its existing investments.

The company had continued to focus heavily on the existing strategic investments, including Kirkstall Limited, Paraytec Limited and Gyrometric Systems Limited, Braveheart said.

Paraytec had recently spun out to its shareholders, Sentinel Medical Limited, a company which would seek to exploit the technology developed by Paraytec to detect cancer cells in urine. Braveheart now held a 32.8% stake in Sentinel and considered this to be a separate strategic investment.

Kirkstall and Paraytec, were consolidated into a one entity as the company owned a stake in excess of 50% in the two companies and was exerting significant managerial control over them.

Braveheart also recently acquired a 21.2% stake in PhaseFocus Holdings, a revenue producing company which used novel computational methods to enhance image quality in both optical and electron microscopes.

'As a result of these developments, Braveheart now holds investments in five Strategic Investments alongside its portfolio of other historic investments,' the company said.

At 8:12am: [LON:BRH] Braveheart Investment Group PLC share price was 0p at 11.25p

Story provided by